Patterns of co-administration and sequential administration of COVID-19 and influenza vaccinations: a US study using Adheris pharmacy dataset.

Alon Yehoshua¹, Tianyan Hu¹, Taryn Pond², Jingyan Yang^1,3, Verna Welch², Constantina Boikos⁴, Sen Deng⁵, Hao Zheng⁵, Poorva Sardana⁶, Neha Agrawal⁶, Manvi Sharma⁶

¹Global Access and Value, Pfizer Inc., New York, NY, USA.

²Vaccines Medical & Scientific Affairs, Pfizer Inc., Collegeville, PA, USA.

³The Institute for Social and Economic Research and Policy, Columbia University, New York, USA.

⁴Vaccines Medical & Scientific Affairs, Pfizer Inc., Kirkland, Quebec, Canada.

⁵Sales Brand Analytics, MedAdvisor Solutions, Woburn, MA, USA.

⁶Real World Evidence, Complete HEOR Solutions LLC., Chalfont, PA, USA.

PubMed DOI

Abstract

BACKGROUND: This study assessed monthly patterns of co-administration of COVID-19 and influenza vaccines at visit level and quantified the number and proportion of adults who received both vaccines on the same day or sequentially. RESEARCH DESIGN AND METHODS: This retrospective study utilized the Adheris pharmacy dataset and included adults aged ≥ 19 years with a record of ≥ 1 dose of COVID-19 or…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.